We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Grifols SA (GRF) Ord Eur0.25 A Shares

Sell:€10.80 Buy:€10.81 Change: €0.13 (1.19%)
Market closed |  Prices as at close on 21 February 2024 | Switch to live prices |
Change: €0.13 (1.19%)
Market closed |  Prices as at close on 21 February 2024 | Switch to live prices |
Change: €0.13 (1.19%)
Market closed |  Prices as at close on 21 February 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies.

Contact details

C/ Jesus y Maria, 6
+34 (935) 710000

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
€6.72 billion
Shares in issue:
678.66 million
Madrid Stock Exchange

Key personnel

  • Thomas Glanzmann
    Executive Chairman of the Board, Chief Executive Officer
  • Nacho Abia
    Chief Executive Officer
  • Alfredo Arroyo Guerra
    Chief Financial Officer
  • Jordi Balsells Valls
    President - Plasma Procurement
  • Maria Pia D'urbano
    President - Biopharma
  • Alberto Grifols Roura
    President - Bio Supplies
  • Antonio Martinez Martinez
    President - Diagnostic
  • Montserrat Gaja Llamas
    Chief Human Resource Officer
  • Fernando Sebastian Rodriguez Haro
    Executive Vice President - Transformation
  • Lluis Pons Gomez
    Senior Vice President - Strategy

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.